Literature DB >> 8362376

Fibrin--recombinant human factor XIII a-subunit association.

R Procyk1, P D Bishop, B Kudryk.   

Abstract

The association of factor XIII a-subunits with fibrin was characterized using recombinant human placental factor XIII (rFXIII) and native fully hydrated fibrin clots formed from purified fibrinogen and thrombin. Binding was assessed using small columns containing fibrin and perfusing them with radioiodinated rFXIII. Results show that thrombin activation of rFXIII led to fibrin binding. The association was partially reversible since much of the bound enzyme could be removed by percolating clots with more buffer. Binding was blocked by antibody directed against the COOH-terminal part of fibrinogen A alpha-chain (A alpha 389-402) and also by the COOH-terminal A alpha-chain peptide fragment A alpha 241-476 (Hi2-DSK).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8362376     DOI: 10.1016/0049-3848(93)90179-r

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  8 in total

1.  Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains.

Authors:  Kevin R Siebenlist; Michael W Mosesson; Irene Hernandez; Leslie A Bush; Enrico Di Cera; John R Shainoff; James P Di Orio; Laurie Stojanovic
Journal:  Blood       Date:  2005-07-07       Impact factor: 22.113

2.  NMR solution structure, stability, and interaction of the recombinant bovine fibrinogen alphaC-domain fragment.

Authors:  Robert A Burton; Galina Tsurupa; Roy R Hantgan; Nico Tjandra; Leonid Medved
Journal:  Biochemistry       Date:  2007-06-23       Impact factor: 3.162

3.  Fibrinogen cleavage by the Streptococcus pyogenes extracellular cysteine protease and generation of antibodies that inhibit enzyme proteolytic activity.

Authors:  Y V Matsuka; S Pillai; S Gubba; J M Musser; S B Olmsted
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Evaluating the Effects of Fibrinogen αC Mutations on the Ability of Factor XIII to Crosslink the Reactive αC Glutamines (Q237, Q328, Q366).

Authors:  Kelly Njine Mouapi; Lucille J Wagner; Chad A Stephens; Mohammed M Hindi; Daniel W Wilkey; Michael L Merchant; Muriel C Maurer
Journal:  Thromb Haemost       Date:  2019-05-05       Impact factor: 5.249

5.  The interaction between fibrinogen and zymogen FXIII-A2B2 is mediated by fibrinogen residues γ390-396 and the FXIII-B subunits.

Authors:  James R Byrnes; Clare Wilson; Anthony M Boutelle; Chase B Brandner; Matthew J Flick; Helen Philippou; Alisa S Wolberg
Journal:  Blood       Date:  2016-08-25       Impact factor: 22.113

6.  Ranking reactive glutamines in the fibrinogen αC region that are targeted by blood coagulant factor XIII.

Authors:  Kelly Njine Mouapi; Jacob D Bell; Kerrie A Smith; Robert A S Ariëns; Helen Philippou; Muriel C Maurer
Journal:  Blood       Date:  2016-03-07       Impact factor: 22.113

7.  Elimination of coagulation factor XIII from fibrinogen preparations.

Authors:  E L Smith; B Cardinali; L Ping; R A S Ariëns; H Philippou
Journal:  J Thromb Haemost       Date:  2013-05       Impact factor: 5.824

8.  Functional and Structural Characterization of Nucleic Acid Ligands That Bind to Activated Coagulation Factor XIII.

Authors:  Nasim Shahidi Hamedani; Arijit Biswas; Oliver Rudan; Rosa Tönges; Carlotta Meyring; Fabian Tolle; Günter Mayer; Johannes Oldenburg; Jens Müller; Bernd Pötzsch
Journal:  J Clin Med       Date:  2021-02-10       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.